Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats.
Koizumi T, Watanabe M, Yokota T, Tsuda M, Handa H, Koya J, Nishino K, Tatsuta D, Natsui H, Kadosaka T, Koya T, Nakao M, Hagiwara H, Kamada R, Temma T, Tanaka S, Anzai T.
Koizumi T, et al. Among authors: kamada r.
Front Cardiovasc Med. 2023 Feb 6;10:1005408. doi: 10.3389/fcvm.2023.1005408. eCollection 2023.
Front Cardiovasc Med. 2023.
PMID: 36815024
Free PMC article.